220 related articles for article (PubMed ID: 8217490)
1. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.
Nakajo M; Nakabeppu Y; Yonekura R; Iwashita S; Goto T
Ann Nucl Med; 1993 Aug; 7(3):157-66. PubMed ID: 8217490
[TBL] [Abstract][Full Text] [Related]
2. High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology.
Lumachi F; Borsato S; Tregnaghi A; Marino F; Fassina A; Zucchetta P; Marzola MC; Cecchin D; Bui F; Iacobone M; Favia G
Tumori; 2007; 93(3):269-74. PubMed ID: 17679462
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy.
Kloos RT; Gross MD; Shapiro B; Francis IR; Korobkin M; Thompson NW
World J Surg; 1997 Jan; 21(1):36-40. PubMed ID: 8943175
[TBL] [Abstract][Full Text] [Related]
5. A case of ganglioneuroma in which 131I-6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol scintigraphy showed high uptake in the adrenal gland leading to a misdiagnosis.
Fukumitsu N; Ashida H; Ogi S; Uchiyama M; Mori Y; Ikemoto I; Sakamoto N; Tojo K; Kawakami M
Ann Nucl Med; 2006 Jan; 20(1):69-73. PubMed ID: 16485578
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the large adrenal mass.
Khafagi FA; Gross MD; Shapiro B; Glazer GM; Francis I; Thompson NW
Br J Surg; 1991 Jul; 78(7):828-33. PubMed ID: 1873713
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic demonstration of renal cell carcinoma with I-131-6beta-iodomethyl-19-norcholesterol: a case report.
Ochotorena IJ; Miyake H; Hori Y; Odo H; Hirata Y; Mori H
Ann Nucl Med; 1999 Dec; 13(6):423-5. PubMed ID: 10656278
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing benign from malignant euadrenal masses.
Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
[TBL] [Abstract][Full Text] [Related]
11. [Differential diagnosis of space-occupying adrenal masses].
Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
[TBL] [Abstract][Full Text] [Related]
12. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
13. Incidentally discovered adrenal masses: a functional and morphological study.
Corsello SM; Della Casa S; Bollanti L; Rufini V; Rota CA; Danza F; Colasanti S; Vellante C; Troncone L; Barbarino A
Exp Clin Endocrinol; 1993; 101(3):131-7. PubMed ID: 8223980
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of the scintigraphy with iodocholesterol (I-COL) to the diagnosis and characterization of silent adrenal masses].
Rodado Marina S; Aguirre Sánchez-Covisa M; García Vicente AM; Poblete García VM; Ruiz Solís S; Cortés Romera M; Soriano Castrejón A
Rev Esp Med Nucl; 2004; 23(3):166-73. PubMed ID: 15153359
[TBL] [Abstract][Full Text] [Related]
15. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Ichijo T; Ueshiba H; Nawata H; Yanase T
Endocr J; 2020 Feb; 67(2):141-152. PubMed ID: 31694993
[TBL] [Abstract][Full Text] [Related]
16. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
17. [Computed tomography of non-functioning adrenal masses].
Andreis M; Avataneo T
Radiol Med; 1985 Apr; 71(4):206-10. PubMed ID: 4048555
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
19. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
20. [Role of adrenocortical scintigraphy in the exploration of incidentally discovered tumors].
Delemer B; Gibold C; Caron J; Liehn JC; Delisle MJ
Ann Endocrinol (Paris); 1992; 53(4):147-52. PubMed ID: 1339063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
